Adverse Effects and Toxicity of Immune Checkpoint Inhibitors For Patients With Urothelial Carcinoma

Urothelial carcinoma (UC) occupies a high incidence among all the genitourinary malignancies. Immune checkpoint inhibitors (ICIs), as alternative treatments of metastatic urothelial carcinoma (mUC), have been applied in the treatment of mUC after chemotherapy failure, with comparable efficacy and sa...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Di, Sun, Kai, Wang, Tianqi, Zhang, Dongxu, Sun, Fengze, Cui, Yuanshan, Zhao, Hongwei, Wu, Jitao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632774/
https://www.ncbi.nlm.nih.gov/pubmed/34867321
http://dx.doi.org/10.3389/fphar.2021.710943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632774/
https://www.ncbi.nlm.nih.gov/pubmed/34867321
http://dx.doi.org/10.3389/fphar.2021.710943

Ejemplares similares